The overall risk of Kaposi's sarcoma (KS) among human immunodeficiency virus type 1 (HIV-1)-infected individuals and those with acquired immunodeficiency syndrome (AIDS-KS) is more than 20 000 times higher than in the uninfected population and 300 times higher than that in the immunosuppressed transplant recipients (1) . Although the mechanisms of its pathogenesis are not well understood, the epidemiologic and laboratory findings clearly indicate that the human herpesvirus 8 (HHV8, also called KS-associated herpesvirus) and HIV-1 play critical roles in the high incidence of KS in HIV-1-infected individuals [reviewed in (2) ]. The earliest evidence to support the role of HIV-1 in AIDS-KS came from transgenic mouse studies showing that HIV-1 transactivator (Tat) can produce KS-like lesions when it is introduced into the germ line of mice (3) . Although Tat expression in both male and female mice was comparable, tumors developed only in male mice, mimicking the male predominance. The expression of the Tat gene was also not observed in tumor cells. However, these findings suggested an important role of Tat in the pathogenesis of AIDS-KS. Numerous studies [reviewed in (4) ] also suggest that inflammatory cytokines produced by infected or activated immune cells play an important role in the pathogenesis of AIDS-KS. Inflammatory cytokines present in the conditioned medium of activated T cells have been shown to support the growth of spindle cells derived from AIDS-KS lesions.
The HIV-1 Tat is an 86-101 amino-acid protein encoded by two exons [reviewed in (5) ]. The product of the first exon (72 amino acids) is sufficient for transactivation of the HIV-1 gene expression from the viral promoter. However, the C-terminal (73-86/101 amino acids) encoded by the second exon contains the arginine-glycine-aspartate (RGD) sequence that is believed to function primarily as a cell-attachment domain and binds cell-surface integrin receptors (6, 7) . Studies (8, 9) have shown that Tat protein released into the extracellular medium by HIV-1 infection of T cells stimulates the growth of AIDS-KS-derived spindle cells. Tat also stimulates the growth of and induces spindle morphology in normal endothelial cells that have been pretreated with inflammatory cytokines (10) . Tat-induced migration, invasion, proliferation, and collagenase IV expression in KS spindle cells and in cytokine-activated endothelial cells in culture indicated that Tat can support angiogenesis (10, 11) . The in vivo angiogenic response of Tat has been demonstrated by subcutaneous injection of purified Tat in mice (11, 12) and in transgenic mice expressing full-length Tat protein (13) (14) (15) . The angiogenic properties of Tat have been mapped to its RGD sequence (6, 7, 11) and to the basic amino-acid region that is similar to that of angiogenic growth factors and binds heparin complexes (16, 17) . Basic fibroblast growth factor (bFGF) and heparin have been shown to significantly enhance the in vivo angiogenic effects of Tat (11, 16) . bFGF and Tat are present in AIDS-KS lesions, and integrin receptors that bind Tat are highly expressed by vessels and spindle cells.
Histologically, KS lesions consist of a heterogeneous population of cells, including characteristic aggregates of spindleshaped cells, fibroblasts, dendritic cells, and a prominent infiltrate of leukocytes and other inflammatory cells (18) . A number of studies [(18) ; reviewed in (19) ] suggest that infiltrating leukocytes in AIDS-KS lesions could be a possible source of HIV-1 Tat, inflammatory cytokines, and HHV8, thereby contributing to the aggressive and rapid growth of tumors. HIV-1 infection of leukocytes is also known to induce synthesis and secretion of matrix metalloproteinases (MMPs), the enzymes that degrade components of the extracellular matrix, and aid cells in traversing the tissues (20) (21) (22) . More recently, HIV-1 Tat protein alone has been shown to increase the production of MMP-9 (92-kd MMP) in monocytes and also to increase their adhesion to endothelial cells (23) , causing them to extravasate into lesions.
In this study, we used transgenic mice expressing two-exonencoded Tat (Tat 86 ) and one-exon-encoded Tat (Tat 72 ) to investigate whether Tat expression will promote the growth and tumorigenic potential of human KS SLK cells subcutaneously injected into these mice. These findings may be relevant for the understanding of the aggressive and rapid course of KS in HIV-1-infected individuals and for the development of targeted anti-AIDS-KS therapies.
MATERIALS AND METHODS

Production of Transgenic Mice
Transgenic mice expressing one-exon-encoded Tat protein (Tat 72 ) and twoexon-encoded Tat protein (Tat 86 ) under the transcriptional control of simian virus 40 promoter were generated as previously described (24) . The heterozygous lines of mice established from the transgenic founders expressed Tat protein in several tissues, including bone marrow cells (24) . The Tat protein was also biologically active as determined by the transactivation of the HIV-1 long terminal repeat (LTR) in doubly transgenic mice carrying both Tat and chloramphenicol acetyltransferase (CAT) reporter gene under the transcription control of the LTR (LTR-CAT) (24) . Tat transgenic mice were routinely identified by the Southern blot analysis of the tail DNA.
Injection of Human KS Cells in Mice
The KS SLK cell line established from a KS lesion of gingiva of an HIV-1-negative immunosuppressed renal transplant recipient (25) was maintained in gelatin-coated flasks as previously described (26) . The SLK cell line is of endothelial origin and, when inoculated in nude mice, induces tumors with endothelial characteristics (27) . Approximately 1 × 10 6 KS SLK cells were mixed with liquid Matrigel (Collaborative Biomedical Products, Bedford, MA) in a final volume of 0.5 mL and injected subcutaneously near the abdominal midline of immunosuppressed Tat transgenic and nontransgenic mice. For activation experiments, KS SLK cells were treated with 10 ng/mL of phorbol 12-myristate 13-acetate (PMA) for 1 hour in culture followed by incubation in medium without PMA for 4 hours before injection in mice. PMA (10 ng/mL) was incorporated in the Matrigel before injection, where indicated. Immunosuppression in mice was induced by weekly intraperitoneal injections of 0.3 mg of GK1.5 (American Type Culture Collection, Manassas, VA) antibody, a rat monoclonal antibody targeting the CD4 molecule (28) . The antibody was partially purified from ascites fluid by the ammonium sulfate precipitation procedure described previously (29) . Flow cytometric analysis of splenic cells with fluorescein isothiocyanate-conjugated anti-CD4 antibody (Pharmingen, San Diego, CA) showed more than a 85% loss of CD4 + T cells 5-7 days after anti-CD4 antibody treatment. Mice were killed to recover Matrigel implants, when necessary, for histologic examination or other procedures.
Gelatin Zymography
For zymography, tumor and tissue extracts were prepared by homogenization and sonication in 0.01 M Tris buffer (pH 7.0) containing 0.01% Triton X-100 followed by centrifugation at 10 000 rpm for 10 minutes at 4°C. The protein content of cell-free supernatants was determined by the Bio-Rad protein assay method (Bio-Rad Laboratories, Hercules, CA) (30) . Gelatinase activity was assayed by electrophoresis of tissue or cell extracts containing 20 g protein on 10% polyacrylamide gels with 0.1% gelatin (NOVEX, San Diego, CA), according to the supplier's instructions. After electrophoresis, the gels were incubated overnight in developing buffer and stained with Coomassie Blue. Proteolytic activity was detected as unstained bands against a blue background. To characterize these bands as MMPs, gels were incubated with developing buffer containing 20 mM EDTA, where indicated.
Isolation of Mouse Mononuclear Cells and Polymorphonuclear Leukocytes
Mononuclear cells (MNCs) and polymorphonuclear leukocytes (PMNs) from mouse blood and bone marrow were isolated by use of a two-component step gradient procedure (Cardinal Associates, Inc., Santa Fe, NM). A light microscopic examination revealed that the isolated PMN and MNC fractions from blood contained 70% and 4% segmented neutrophils, respectively. On the other hand, the PMN and MNC fractions from bone marrow contained 54% and 80% neutrophils, respectively.
RNA Extraction and Reverse Transcription-Polymerase Chain Reaction for Quantitation of Tat and Cytokine Messenger RNAs From Tumor Tissues
Total cellular RNA from liquid nitrogen-frozen tissues was extracted by use of the Rneasy Mini Kit (Qiagen, Valencia, CA), according to the supplier's instructions. To eliminate DNA contamination, extracted RNA was treated with ribonuclease-free deoxyribonuclease. The final preparation was quantitated spectrophotometrically, examined for the presence of 18S and 28S ribosomal RNA bands, and stored at −70°C until use.
Reverse 
Statistical Analysis
Student's t test was applied to estimate the statistical significance of difference (33) in the tumor weights from nontransgenic mice, Tat 72 -, and Tat 86 -transgenic mice. All P values were two-sided.
RESULTS
Human KS SLK Cell-Derived Tumorigenic Response in Tat-Transgenic Mice
Earlier studies (24) have shown that the transgenic mice carrying the one-exon Tat gene (Tat 72 ) and the two-exon Tat gene (Tat 86 ) express detectable levels of Tat protein in several tissues. Tat is also biologically active in these mice, as seen by the transactivation of the HIV-1 LTR in doubly transgenic mice carrying both Tat and LTR-CAT transgenes (24) . To determine whether HIV-1 Tat expression influences the tumorigenic potential of human KS cells, we compared the tumorigenicity of KS SLK cells in nontransgenic and Tat-transgenic mice. All nontransgenic and Tat-transgenic mice developed tumors in 3-4 weeks after inoculation with KS SLK cells. However, the tumor growth response in the three lines of mice was different. In general, the tumor growth in Tat 86 mice was considerably higher than that in nontransgenic animals, whereas an intermediate growth response was seen in Tat 72 mice (Fig. 1) . A statistical analysis performed on the weight differences in tumors obtained from each of the lines of mice revealed a sixfold to sevenfold higher tumor growth in Tat 86 mice (∼600 mg) compared with nontransgenic mice (∼100 mg) and a twofold to threefold higher tumor growth in Tat 72 mice (∼200 mg) (Fig. 2) . The average tumor weight in Tat 86 mice was statistically significantly greater than that in the other two groups (P<.005). The observed difference between the Tat 72 and the nontransgenic groups was not statistically significant (P ‫ס‬ .1). These observations clearly indicated that Tat 86 and, to a lesser extent, Tat 72 promote the growth of KS SLK cell-derived tumors in Tat transgenic mice.
Histologic examination of tumors by light microscopy showed spindle-shaped SLK cells (Fig. 3 , large arrow) with a prominent infiltrate of inflammatory cells (small arrow). The tumor cell growth in culture showed morphologic features of the parental SLK cells (not shown).
NF-B p50 and Cytokine mRNA Expression in KS SLK Cell-Derived Tumors in Tat-Transgenic Mice
Numerous studies [reviewed in (4) ] have suggested that inflammatory cytokines that are elevated in HIV-1-infected individuals and cytokines produced by AIDS-KS cells cooperate with HIV-1 Tat in the development of AIDS-KS. To test the possibility that Tat and certain inflammatory cytokines might play a role in the enhanced tumor growth in Tat-transgenic mice, we measured the expression of a number of cytokines, such as interleukin 2 (IL-2), interleukin 4 (IL-4), interleukin 6 (IL-6), interleukin 8 (IL-8), interleukin 1␣ (⌱L-1␣), interleukin 1␤ (IL-1␤), tumor necrosis factor-␣ (TNF-␣), interferon gamma (IFN ␥), granulocyte-macrophage colony-stimulating factor (GM-CSF), and bFGF. Since the two-exon-encoded Tat is the predominant form of Tat produced during HIV-1 infection and the observed difference between the tumors in one-exonencoded Tat (Tat 72 ) and the nontransgenic group was not statistically significant, we randomly selected four tumors from nontransgenic and Tat 86 -transgenic mice for analysis by the semiquantitative RT-PCR method as described in the "Materials and Methods" section. As shown in Fig. 4 , all of the tumors from Tat-transgenic mice showed the expression of Tat mRNA, suggesting that the infiltrating mouse cells actively expressed Tat. The comparative profile of cytokine expression in tumors from the Tat-transgenic and nontransgenic mice showed substantial The SLK cells were grown and subcutaneously injected in mice as described in the "Materials and Methods" section. Four to 5 weeks after injection, the animals were killed and the Matrigel implants were recovered and weighed. differences, although GAPDH expression in all of the tumors was comparable. Four of four tumors from Tat-transgenic mice showed expression of TNF-␣, IL-6, IL-8, and bFGF compared with only two tumors from the nontransgenic group. The level of mRNA expression was also higher in the tumors from Tat mice than in the tumors from nontransgenic mice. Of interest, three of the four tumors from Tat mice showed expression of GM-CSF, but no expression was detectable in the tumors from nontransgenic animals. The expression of ⌱L-2, IL-4, IL-1␤, and IFN ␥ mRNAs was undetectable in all tumors. The transcription factor NF-B is known to play a key role in the expression of a number of genes involved in inflammatory responses and cellular growth regulation (34, 35) . The most abundant form of NF-B is a complex composed of p50-p65 heterodimer belonging to the Rel family. In most cells, NF-B/Rel proteins are sequestered in the cytoplasm by any of several inhibitor proteins IB. Activation of NF-B involves IB degradation and subsequent translocation of NF-B/Rel proteins to the cell nucleus. Earlier reports (36) (37) (38) have indicated that extracellular Tat can induce the activation of NF-B. In this study, we found that NF-B p50-related transcripts in three of the four tumors from Tat mice were substantially elevated, whereas negligible transcription was observed in the tumors from nontransgenic animals. The results of cytokine mRNA analysis suggested that exposure of KS SLK cells to extracellular Tat and to certain inflammatory cytokines might play a role in the enhanced growth of KS SLK cellderived tumors in Tat mice.
Secretion of Leukocyte-Specific MMP in Tumors From Tat Mice
The KS-derived cells in culture have been shown to constitutively release MMPs into the culture supernatants, suggesting that these cells constitutively have an invasive and metastasizing potential (39) . To determine whether tumors from Tat-transgenic mice produced increased levels of MMPs that contributed to more aggressive tumor growth, we performed gelatin zymography. As shown in (39) have reported that human KS cells produce a 92-kd MMP activity. We also found a similar activity produced by the KS SLK cells (not shown), suggesting that the 105-kd specific activity in our study originated from infiltrating mouse cells in the tumors. We next screened mouse tissues to determine the source of the 105-kd MMP activity. As shown in Fig. 6 , A, of all the tissues examined, abundant activity was detectable only in the bone marrow. For the determination of the cell type specificity of the 105-kd MMP, bone marrow cells were fractionated into MNCs and PMNs by gradient centrifugation, and the fractions were analyzed by gelatin zymography. We also determined if a similar activity was present in MNC and PMN fractions collected from mouse blood. As shown in Fig. 6, B (lanes 1-4) , the 105-kd MMP activity was detectable almost entirely in the blood-derived PMN fraction (lane 2); only a negligible activity was seen in the MNC fraction (lane 1). In contrast, in the bone marrow, substantial activity was observed in both fractions (lanes 3 and 4) . A light microscopic examination (Fig. 7, A-D) of the MNC and PMN fractions from blood and bone marrow from tumor-bearing and control mice revealed that PMN fractions (Fig. 7 , A and C) were mainly (>75%) composed of segmented neutrophils, suggesting that these neutrophils might be the source of 105-kd MMP activity. The abundance of MMP 1-4) and Tat 86 -transgenic mice (lanes 5-8) . The semiquantitative reverse transcription-polymerase chain reaction analysis was carried out as described in the "Materials and Methods" section. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene expression was used as an internal control. Since there was no statistically significant difference between the tumors in Tat 72 -transgenic and the nontransgenic groups, the comparison was made only between the Tat 86 -transgenic and the nontransgenic groups. bFGF ‫ס‬ basic fibroblast growth factor; GM-CSF ‫ס‬ granulocyte-macrophage colonystimulating factor; IL-8 ‫ס‬ interleukin 8; IL-6 ‫ס‬ interleukin 6; TNF-␣ ‫ס‬ tumor necrosis factor-␣. activity in the MNC fraction obtained from bone marrow (Fig. 7 , D) might also be attributed to segmented neutrophils, since these cells were abundantly present in this fraction. On the other hand, a limited presence (∼4%) of segmented neutrophils in the MNC fraction from blood (Fig. 7, B) was associated with the negligible 105-kd MMP activity. In conclusion, the results of these experiments suggested that the 105-kd MMP activity predominantly observed in the tumors from Tat 86 -transgenic mice might be associated with the infiltrating host neutrophils.
Extravasation of Circulating Leukocytes Into Lesions
The KS lesions contain a prominent infiltrate of blood cells. These cells in HIV-1-infected individuals could contribute to tumor growth through the release of inflammatory cytokines and Tat protein. To determine whether the KS SLK cells attract and bind circulating leukocytes that secrete 105-kd MMP, we inoculated KS SLK cells mixed with Matrigel into nontransgenic mice and assessed the extent of leukocyte infiltration. Subcutaneously injected Matrigel alone was used as a control. As shown in Fig.  8 (lanes 1-4) , the KS SLK cell pellet showed substantially higher gelatinase activity than the Matrigel pellet (compare lanes 3 and 1). The activity was further increased substantially (lane 4) by pretreatment of the KS cells in culture with PMA, whereas PMA alone in Matrigel had a minimal effect (lane 2). The changes in the MMP activity (lanes 3 and 4) were associated with the extravasation of leukocytes (not shown) into the SLK cell pellets. Since PMA, lipopolysaccharides, and certain cytokines, such as TNF-␣, IL-1␤, and IL-8, are known to increase the chemotaxis and adhesion of leukocytes to primary endothelial cells and KS cells (41) (42) (43) , our observations suggested that activation of KS SLK cells increased their adhesion for leukocytes that could, in turn, stimulate a local inflammatory response for the development of KS.
DISCUSSION
Several lines of experimental evidence now suggest that HIV-1 plays an active role in the pathogenesis of AIDS-KS through the cooperative effects of inflammatory cytokines produced by infected and activated immune cells and the HIV-1-encoded Tat protein [reviewed in (4) ]. In this article, we provide the first evidence that Tat expression is associated with growth of KS SLK cell-induced tumors in Tat-transgenic mice. The tumor growth in Tat 86 mice was sixfold to sevenfold higher than that in the nontransgenic animals. An earlier study (44) has shown that picomolar concentrations of Tat released into the extracellular medium by infected cells can promote the growth of cells derived from KS lesions of AIDS patients. Subsequently, it was found that Tat can significantly enhance the growth-promoting effects of inflammatory cytokines that are growth factors for AIDS-KS spindle cells (10) . Extracellular Tat stimulates growth and induces spindle morphology in normal endothelial cells that have been exposed to inflammatory cytokines. Inflammatory cytokines also induce AIDS-KS cells to release bFGF, a potent autocrine growth factor that promotes growth and angiogenesis of AIDS-KS cells (45) . In vivo, the proliferative and angiogenic responses of bFGF are synergistically enhanced by purified Tat (11) .
In addition to other sources of inflammatory cytokine production in HIV-1-infected individuals [reviewed in (4)], Tat itself has been shown to modulate the expression of a number of cytokines. Lafrenie et al. (46) have shown that treatment of monocytes with purified Tat in culture enhances the production of IL-1␤, IL-6, IL-8, and TNF-␣ and their respective mRNAs. In other studies, induced cellular expression of Tat in cells has been shown to increase the expression of IL-2 (47), , and TNF-␤ (49, 50) . Tat expression in transgenic mice has been shown to increase the expression of TNF-␤ and TGF-␤ (51) as well as IL-6 and IL- 10 (52,53) . In our study, the HIV-1 Tat protein could promote the growth of SLK cell-derived tumors in Tat-transgenic mice in a number of ways. Since the tumors contain a prominent infiltrate of mouse blood cells, these cells could provide exogenous Tat. As shown in Fig. 4 , Tat mRNA is abundantly expressed in the tumors from Tat 86 mice. We have previously reported that these mice also show readily detectable levels of Tat protein in most tissues, including the bone marrow cells (24) . In addition to bFGF expression, these tumors also show substantial increases in the mRNA levels for TNF-␣, IL-6, IL-8, and GM-CSF. These are some of the cytokines that have an autocrine/paracrine role in the proliferative activity of AIDS-KS, and their activity is further augmented in the presence of Tat protein [reviewed in (4) ].
Several reports (36, 37, 54) have demonstrated that extracellular Tat is associated with activation of transcription factor NF-B. The major form of NF-B is composed of a p50 and p65 heterodimer. In this study, we found that the expression of p50 transcripts is significantly increased in tumors from Tat mice but not in tumors from nontransgenic mice. Although we have not examined the expression of the p65 subunit, its stochiometric appearance with p50 (55) suggests that the induction of the native NF-B complex might be increased as well in the tumors from Tat mice. NF-B is involved in the transcriptional regulation of a number of inflammatory cytokines [reviewed in (56, 57) ]. Aberrant NF-B activity is also associated with enhanced cell proliferation and oncogenesis. For example, constitutive NF-B activation is required for proliferation and survival of many cells, including breast cancer cells (58) and Hodgkin's lymphoma cells (59) . Consistent with these observations, it is conceivable that NF-kB might participate in tumor progression in Tat transgenic mice.
Tat contains several functional domains. Previous studies (7, 15) have shown that binding of extracellular Tat to the cell surface is mediated by two distinct domains: a basic domain (amino acids 42-64) and a C-terminal domain (amino acids 65-80) containing the RGD sequence that binds cell-surface intergrin receptors (6) . The same intergrins are highly expressed by KS spindle cells and are inducible by inflammatory cytokines on endothelial cells (7) . The basic domain of Tat is similar to that of several growth factors [reviewed in (60) ] and mediates binding of Tat to Flk-1/KDR, a receptor for vascular endothelial growth factor-A, which is a potent growth factor for AIDS-KS cells (61) . Interaction of extracellular Tat with these receptors can induce the growth and migration of endothelial and KS cells (7, 11, 17, 60) . In our study, the selective presence of RGD in Tat 86 might explain the enhanced tumor growth in Tat 86 mice over that in Tat 72 mice.
Numerous studies (20) (21) (22) have suggested that, in addition to providing inflammatory cytokines and viral Tat, the infiltrating HIV-1-infected leukocytes in KS lesions could also be a source of MMPs, which are essential for tumor invasion and metastasis. MMP secretion has been shown to be increased in HIV-1-infected T lymphocytes, monocytes, and macrophages (20) (21) (22) . In addition, treatment of monocytes with soluble Tat in culture has been shown to increase the production of MMP-9 (23) . In this study, we found that the mouse neutrophil-associated 105-kd gelatinase activity was significantly increased in all of the tumors from Tat 86 mice. Although the mechanism of its activation remains to be explored, our observations suggest that this MMP might also play a role in the accelerated growth of KS SLK cell-derived tumors in Tat 86 mice.
In conclusion, our in vivo study strengthens the role of extracellular Tat and inflammatory cytokines on the pathogenesis of AIDS-KS and may provide one of the explanations for why KS is a more aggressive disease in HIV-infected individuals. Our transgenic mouse model may be useful to study the efficacy of the anti-KS therapies, especially those targeting Tat activity.
